BCA
GILD icon

Berman Capital Advisors’s Gilead Sciences GILD Stock Holding History

Berman Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$309K Buy
4,438
+1,744
+65% +$123K 0.05% 197
2021
Q2 		$185K Buy
2,694
+728
+37% +$48.6K 0.03% 249
2021
Q1 		$126K Buy
1,966
+455
+30% +$29.3K 0.03% 257
2020
Q4 		$88K Buy
1,511
+7
+0.5% +$422 0.02% 275
2020
Q3 		$94K Sell
1,504
-638
-30% -$44.2K 0.03% 235
2020
Q2 		$163K Sell
2,142
-294
-12% -$22.5K 0.04% 164
2020
Q1 		$181K Buy
2,436
+911
+60% +$62.9K 0.06% 131
2019
Q4 		$98K Buy
1,525
+66
+5% +$4.3K 0.03% 220
2019
Q3 		$92K Sell
1,459
-109
-7% -$7.13K 0.03% 219
2019
Q2 		$105K Buy
1,568
+192
+14% +$12.6K 0.03% 202
2019
Q1 		$89K Buy
1,376
+285
+26% +$18.9K 0.03% 205
2018
Q4 		$67K Buy
+1,091
New +$76.3K 0.03% 222

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berman Capital Advisors's GILD Position: Q3 2021 in Review

Berman Capital Advisors increased its Gilead Sciences (GILD) stake by 65% in Q3 2021, buying an estimated $123K and bringing the position to 4,438 shares worth $309K. The position accounts for 0.05% of the portfolio, ranked #197.

Berman Capital Advisors first reported a position in GILD in Q4 2018 and has held it in 12 quarters since. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • Berman Capital Advisors held 4,438 shares of Gilead Sciences worth $309K as of Q3 2021.
  • Berman Capital Advisors bought 1,744 Gilead Sciences shares in Q3 2021, an estimated $123K.
  • Gilead Sciences made up 0.05% of Berman Capital Advisors's portfolio in Q3 2021, its #197 holding.
  • Berman Capital Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 12 quarters since.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.